Find your next paid study

University of Central FloridaNCT07214246

~$10 – $750

Treatment Resistant Depression (TRD)

Neuronavigated and Non-Neuronavigated Accelerated Intermittent Theta-Burst Stimulation for Treatment-Resistant Depression A Sham-Controlled Randomized Controlled Trial

The purpose of this study is to confirm the efficacy of two recently introduced repetitive transcranial magnetic stimulation (rTMS) interventions - accelerated…

University of Texas Southwestern Medical CenterNCT07329153

Phase 1

Phase 1, Randomized, Double-Blind, Placebo-Controlled Trial of Pulse Dosed Ceftriaxone for Post-Treatment Lyme Disease

The goal of this clinical trial is to learn if an FDA approved drug, Ceftriaxone, given intermittently, can treat people between 18 and 75 years old with a his…

Post-Treatment Lyme Disease

State University of New York - Upstate Medical UniversityNCT06611111

ParentingParent-Child RelationsChild Behavior+1 more

Delivering Evidence-Based Parenting Services to Families in Child Welfare Using Telehealth

The goal of this randomized controlled trial is to compare Promoting First Relationships - Home Visit (PFR-HV) to Promoting First Relationships - Telehealth (P…

Documented

$75/visit

University of WashingtonNCT06109766

Phase 1

EEG Biomarker Development for Ketamine Administration

We will be developing an EEG-based biomarker for the effects of ketamine infusion in patients with Depression. We will be analyzing the effects of ketamine inf…

Treatment Resistant Depression (TRD)

Soterix MedicalNCT07307768

~$10 – $7,500

Child MaltreatmentParentingChild Wellbeing

Thrive Initiative Domestic and Chlid Abuse Prevention Programming Study

The purpose of this study is to evaluate the effectiveness of the Thrive Initiative's parent-education program delivery methods by comparing hybrid (i.e., a co…

Penn State UniversityNCT06823518

Phase 2

The 'SWIVEL' Study (Switch Vs Effects Relief): Effectiveness of a Medication 'Switch' vs Guideline-Directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

Researchers have learned that about 50% of women do not finish the standard 5-year breast cancer treatment with an aromatase inhibitor. An aromatase inhibitor …

Breast CancerAdjuvant TreatmentEarly Stage Breast Cancer

Dartmouth-Hitchcock Medical CenterNCT07071038

Phase 3

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib in Participants ≥18 Years of Age With Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen

Study CL3-95031-007 (CHONQUER) is a Phase 3, international, multicenter, double-blind, randomized, placebo-controlled study of orally administered ivosidenib. …

Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen

Servier Bio-Innovation LLCNCT06127407

~$10 – $8,750

Unhide® Project Also Known as The Unhide® Solve Together Unified Platform

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle i…

Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more

Treatment Resistant DepressionMajor Depressive EpisodeMajor Depression+4 more

~$10 – $1,125

University of Iowa Interventional Psychiatry Service Patient Registry

The purpose of this study is to examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and Obsessive-Compulsive Di…

Post-Treatment Lyme Disease Syndrome

~$10 – $1,125

Mark NiciuNCT04480918

Phase 1

Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Trial of Pulse Dosed Ceftriaxone for Post-Treatment Lyme Disease

Lyme disease is a public health crisis in the US. It is estimated that over 400,000 cases occur every year with 10-20% of those infected going on to develop Po…

Hackensack Meridian HealthNCT06785402

~$10 – $7,500

Major Depressive DisorderTreatment Resistant Depression

Maintaining the Acute Therapeutic Effect of rTMS in Treatment-Resistant Depression (Maitr-De)

Repetitive transcranial magnetic stimulation (rTMS) has emerged as a promising intervention for treatment-resistant depression (TRD), yet substantial uncertain…